Peter Damman - Concepedia

Author

Peter Damman

Also Known As

D. A. M. Peeters, Damman, P., N. P. G. Hoedemaker, P Damman, P. Damman, PETER DAMMAN, Peter Damman, Peter E Damman, Pierre Gaborit, R. Dennert

234

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

University of Amsterdam Amsterdam UMC Location University of Amsterdam Radboud University Nijmegen Radboud University Medical Center Isala

About

Peter Damman is an author at University of Amsterdam specializing in cardiovascular disease, cardiology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	859
2	Public Health	9	9	464
3	Engineering	1	1	43
4	Biomedical Engineering	1	1	43
5	Diabetes	1	1	53

Peter Damman

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Physiological Basis and Long-Term Clinical Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve in Coronary Stenoses of Intermediate Severity Tim P. van de Hoef, Martijn A. van Lavieren, Peter Damman, Circulation Cardiovascular Interventions	2014	372
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt, Circulation	2022	142
5-Year Clinical Outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) Trial Peter Damman, Alexander Hirsch, Fons Windhausen, Journal of the American College of Cardiology Percutaneous Coronary InterventionCardiovascular DiseaseVascular SurgeryOutcomes ResearchCardiology	2010	132
Impact of hyperaemic microvascular resistance on fractional flow reserve measurements in patients with stable coronary artery disease: insights from combined stenosis and microvascular resistance assessment Tim P. van de Hoef, Froukje Nolte, Mauro Echavarría‐Pinto, Heart	2014	120
Multiple Biomarkers at Admission Significantly Improve the Prediction of Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction Peter Damman, Marcel A.M. Beijk, Wichert J. Kuijt, Journal of the American College of Cardiology Biomarker ResearchPercutaneous Coronary InterventionCardiovascular DiseaseBiomarkersAdmission Significantly Improve	2010	100
Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in ANOCA Tijn P.J. Jansen, Regina E. Konst, Annemiek de Vos, JACC. Cardiovascular imaging Cardiovascular DiseaseAtherosclerosisPharmacologyCardiovascular PharmacologyVascular Biology	2022	97
Diagnostic Accuracy of Combined Intracoronary Pressure and Flow Velocity Information During Baseline Conditions Tim P. van de Hoef, Froukje Nolte, Peter Damman, Circulation Cardiovascular Interventions	2012	95
Impact of Coronary Microvascular Function on Long-term Cardiac Mortality in Patients With Acute ST-Segment–Elevation Myocardial Infarction Tim P. van de Hoef, Matthijs Bax, Martijn Meuwissen, Circulation Cardiovascular Interventions	2013	91
Predictors and Permanency of Cardiac Conduction Disorders and Necessity of Pacing after Transcatheter Aortic Valve Implantation Kirsten Boerlage‐van Dijk, Kirsten M. Kooiman, Ze Yie Yong, Pacing and Clinical Electrophysiology	2014	84
Impaired Coronary Autoregulation Is Associated With Long-term Fatal Events in Patients With Stable Coronary Artery Disease Tim P. van de Hoef, Matthijs Bax, Peter Damman, Circulation Cardiovascular Interventions	2013	81

Page 1